academic article

• Loflin, M. J. E., Kiluk, B. D., Huestis, M. A., Aklin, W. M., Budney, A. J., Carroll, K. M., D'Souza, D. C., Dworkin, R. H., Gray, K. M., Hasin, D. S., Lee, D. C., Le Foll, B., et al. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda Drug and Alcohol Dependence  2020 212  DOI:10.1016/j.drugalcdep.2020.107993  PMID:32360455  PMCID:PMC7293929
• Ray, L. A., Grodin, E. N., Leggio, L., Bechtholt, A. J., Becker, H., Ewing, S. F. W., Jentsch, J. D., King, A. C., Mason, B. J., O'Malley, S., MacKillop, J., Heilig, M., et al. The future of translational research on alcohol use disorder Addiction Biology  2020  DOI:10.1111/adb.12903  PMID:32286721
• Falk, D. E., Ryan, M. L., Fertig, J. B., Devine, E. G., Cruz, R., Brown, E. S., Burns, H., Salloum, I. M., Newport, D. J., Mendelson, J., Galloway, G., Kampman, K., et al. Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety Alcoholism-Clinical and Experimental Research  2019 43:158-169  DOI:10.1111/acer.13917  PMID:30403402  PMCID:PMC6317996
• Frantz, K., Roberto, M., Mason, B., Koob, G. F., Volkow, N., de Fonseca, F. R. Larry Parsons: Researcher, mentor, and friend Addiction Biology  2018 23:1204-1206  DOI:10.1111/adb.12686  PMID:30485629
• Mason, B. J., Quello, S., Shadan, F. Gabapentin for the treatment of alcohol use disorder Expert Opinion on Investigational Drugs  2018 27:113-124  DOI:10.1080/13543784.2018.1417383  PMID:29241365
• Mason, B. J. Emerging pharmacotherapies for alcohol use disorder Neuropharmacology  2017 122:244-253  DOI:10.1016/j.neuropharm.2017.04.032  PMID:28454983
• Koob, G. F., Mason, B. J. Existing and future drugs for the treatment of the dark side of addiction Annual Review of Pharmacology and Toxicology  2016 56:299-322  DOI:10.1146/annurev-pharmtox-010715-103143  PMID:26514207
• Vendruscolo, L. F., Estey, D., Goodell, V., Macshane, L. G., Logrip, M. L., Schlosburg, J. E., McGinn, M. A., Zamora-Martinez, E. R., Belanoff, J. K., Hunt, H. J., Sanna, P. P., George, O., et al. Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals Journal of Clinical Investigation  2015 125:3193-3197  DOI:10.1172/jci79828  PMID:26121746
• Araos, P., Pedraz, M., Serrano, A., Lucena, M., Barrios, V., Garcia-Marchena, N., Campos-Cloute, R., Ruiz, J. J., Romero, P., Suarez, J., Baixeras, E., de la Torre, R., et al. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity Addiction Biology  2015 20:756-772  DOI:10.1111/adb.12156  PMID:24854157
• Mason, B. J. Acamprosate, alcoholism, and abstinence Journal of Clinical Psychiatry  2015 76:E224-E225  DOI:10.4088/JCP.14com09632  PMID:25742214
• Perney, P., Rigole, H., Mason, B., Dematteis, M., Lehert, P. Measuring sleep disturbances in patients with alcohol use disorders: a short questionnaire suitable for routine practice Journal of Addiction Medicine  2015 9:25-30  DOI:10.1097/adm.0000000000000063  PMID:25629883
• Mason, B. J., Quello, S., Goodell, V., Shadan, F., Kyle, M., Begovic, A. Gabapentin treatment for alcohol dependence: a randomized clinical trial JAMA Internal Medicine  2014 174:70-77  DOI:10.1001/jamainternmed.2013.11950  PMID:24190578  PMCID:PMC3920987
• Mason, B. J., Higley, A. E. A translational approach to novel medication development for protracted abstinence Current Topics in Behavioral Neurosciences  2013 13:647-70  DOI:10.1007/7854_2012_201  PMID:22351425
• Mason, B. J., Crean, R., Goodell, V., Light, J. M., Quello, S., Shadan, F., Buffkins, K., Kyle, M., Adusumalli, M., Begovic, A., Rao, S. A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults Neuropsychopharmacology  2012 37:1689-1698  DOI:10.1038/npp.2012.14  PMID:22373942  PMCID:PMC3358737
• Higley, A. E., Koob, G. F., Mason, B. J. Treatment of alcohol dependence with drug antagonists of the stress response Alcohol Research: Current Reviews  2012 34:516-521  PMID:23584117  PMCID:PMC3860394
• Mason, B. J., Lehert, P. Acamprosate for alcohol dependence: A sex-specific meta-analysis based on individual patient data Alcoholism-Clinical and Experimental Research  2012 36:497-508  DOI:10.1111/j.1530-0277.2011.01616.x  PMID:21895717  PMCID:PMC3288465
• Perney, P., Lehert, P., Mason, B. J. Sleep disturbance in alcoholism: Proposal of a simple measurement, and results from a 24-week randomized controlled study of alcohol-dependent patients assessing acamprosate efficacy Alcohol and Alcoholism  2012 47:133-139  DOI:10.1093/alcalc/agr160  PMID:22218671
• Higley, A. E., Crane, N. A., Spadoni, A. D., Quello, S. B., Goodell, V., Mason, B. J. Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals Psychopharmacology  2011 218:121-129  DOI:10.1007/s00213-011-2355-8  PMID:21607563  PMCID:PMC3191263
• Crean, R. D., Crane, N. A., Mason, B. J. An evidence-based review of acute and long-term effects of cannabis use on executive cognitive functions Journal of Addiction Medicine  2011 5:1-8  DOI:10.1097/ADM.0b013e31820c23fa  PMID:21321675  PMCID:PMC3037578
• Crean, R. D., Tapert, S. F., Minassian, A., MacDonald, K., Crane, N. A., Mason, B. J. Effects of chronic, heavy cannabis use on executive functions Journal of Addiction Medicine  2011 5:9-15  DOI:10.1097/ADM.0b013e31820cdd57  PMID:21643485  PMCID:PMC3106308
• Mason, B. J., Heyser, C. J. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence CNS & Neurological Disorders-Drug Targets  2010 9:23-32  DOI:10.2174/187152710790966641  PMID:20201812  PMCID:PMC2853976
• Mason, B. J., Lehert, P. The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy American Journal on Addictions  2010 19:147-154  DOI:10.1111/j.1521-0391.2009.00013.x  PMID:20163387
• Mason, B. J., Heyser, C. J. The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence Expert Opinion on Drug Safety  2010 9:177-188  DOI:10.1517/14740330903512943  PMID:20021295
• Mason, B. J., Shaham, Y., Weiss, F., Le, A. D. Stress, alcohol craving, and relapse risk: mechanisms and viable treatment targets Alcohol  2009 43:541-543  DOI:10.1016/j.alcohol.2009.09.024  PMID:19913197  PMCID:PMC2805701
• Mason, B. J., Lehert, P. Effects of nicotine and illicit substance use on alcoholism treatment outcomes and acamprosate efficacy Journal of Addiction Medicine  2009 3:164-171  DOI:10.1097/ADM.0b013e3181917d53  PMID:21769013
• Koob, G. F., Lloyd, G. K., Mason, B. J. Development of pharmacotherapies for drug addiction: a Rosetta stone approach Nature Reviews Drug Discovery  2009 8:500-515  DOI:10.1038/nrd2828  PMID:19483710  PMCID:PMC2760328
• Mason, B. J., Light, J. M., Williams, L. D., Drobes, D. J. Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: Effects of gabapentin Addiction Biology  2009 14:73-83  DOI:10.1111/j.1369-1600.2008.00133.x  PMID:18855801  PMCID:PMC2758315
• Mason, B. J., Light, J. M., Escher, T., Drobes, D. J. Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics Psychopharmacology  2008 200:141-150  DOI:10.1007/s00213-008-1192-x  PMID:18604601  PMCID:PMC2758314
• Mason, B. J., Crean, R. Acamprosate in the treatment of alcohol dependence: clinical and economic considerations Expert Review of Neurotherapeutics  2007 7:1465-77  DOI:10.1586/14737175.7.11.1465  PMID:17997696
• Mason, B. J., Goodman, A. M., Chabac, S., Lehert, P. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation Journal of Psychiatric Research  2006 40:383-393  DOI:10.1016/j.jpsychires.2006.02.002  PMID:16546214
• Anton, R. F., O'Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., Longabaugh, R., Mason, B. J., et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial JAMA-Journal of the American Medical Association  2006 295:2003-2017  DOI:10.1001/jama.295.17.2003  PMID:16670409
• Johnson, B. A., Koob, G. F., Schuckit, M. A., Mason, B. J., Ait-Daoud, N. Understanding and treating alcohol dependence Alcoholism-Clinical and Experimental Research  2006 30:567-584  DOI:10.1111/j.1530-0277.2005.00066.x  PMID:16499499
• Kranzler, H. R., Mueller, T., Cornelius, J., Pettinati, H. M., Moak, D., Martin, P. R., Anthenelli, R., Brower, K. J., O'Malley, S., Mason, B. J., Hasin, D., Keller, M. Sertraline treatment of co-occurring alcohol dependence and major depression Journal of Clinical Psychopharmacology  2006 26:13-20  DOI:10.1097/01.jcp.0000194620.61868.35  PMID:16415699
• Mason, B. J. Acamprosate for alcohol dependence: an update for the clinician FOCUS: The Journal of Lifelong Learning in Psychiatry  2006 4:505-511
• Mason, B. J. Acamprosate in the treatment of alcohol dependence Expert Opinion on Pharmacotherapy  2005 6:2103-2115  DOI:10.1517/14656566.6.12.2103  PMID:16197362
• O'Malley, S. S., Martin, D. J., Hosking, J. D., Mason, B. J. How pilot studies improve large-scale clinical trials: lessons learned from the COMBINE Study Journal of Studies on Alcohol  2005 15:66-71  PMID:16223058
• Mason, B. J. Rationale for combining acamprosate and naltrexone for treating alcohol dependence Journal of Studies on Alcohol  2005 15:148-156  PMID:16223066
• Mason, B. J. Acamprosate Recent Developments in Alcoholism  2003 16:203-215  PMID:12638639
• Mason, B. J. Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessment European Neuropsychopharmacology  2003 13:469-475  DOI:10.1016/j.euroneuro.2003.08.009  PMID:14636963
• Anton, R., Randall, C., Latham, P., Ciraulo, D., LoCastro, J., Donovan, D., Kivlahan, D., Saxon, A., Johnson, B., Roache, J., Tiouririne, N. A. D., Mason, B., et al. Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE study): a pilot feasibility study Alcoholism-Clinical and Experimental Research  2003 27:1123-1131  DOI:10.1097/01.alc.0000078020.92938.0b  PMID:12878918
• Anton, R., Randall, C., Latham, P., Ciraulo, D., LoCastro, J., Donovan, D., Kivlahan, D., Saxon, A., Johnson, B., Roache, J., Mason, B., Salvato, F., et al. Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods Alcoholism-Clinical and Experimental Research  2003 27:1107-1122  DOI:10.1097/01.alc.0000086765.46408.64  PMID:12878917
• Mason, B. J., Goodman, A. M., Dixon, R. M., Hameed, M. H. A., Hulot, T., Wesnes, K., Hunter, J. A. A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone Neuropsychopharmacology  2002 27:596-606  DOI:10.1016/s0893-133x(02)00368-8  PMID:12377396
• Xie, S., Suckow, R. F., Mason, B. J., Allen, D., Cooper, T. B. Rapid and sensitive determination of nalmefene in human plasma by gas chromatography-mass spectrometry Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences  2002 773:143-149  DOI:10.1016/s1570-0232(02)00138-1  PMID:12031840
• Koob, G. F., Mason, B. J., De Witte, P., Littleton, J., Siggins, G. R. Potential neuroprotective effects of acamprosate Alcoholism-Clinical and Experimental Research  2002 26:586-592  DOI:10.1111/j.1530-0277.2002.tb02578.x  PMID:11981137
• Boening, J. A. L., Lesch, O. M., Spanagel, R., Wolffgramm, J., Narita, M., Sinclair, D., Mason, B. J., Wiesbeck, G. A. Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials Alcoholism-Clinical and Experimental Research  2001 25:127S-131S  DOI:10.1097/00000374-200105051-00022  PMID:11391061
• Mason, B. J. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review Journal of Clinical Psychiatry  2001 62:42-48  PMID:11584875
• Mason, B. J., Ownby, R. L. Acamprosate for the treatment of alcohol dependence: a review of double-blind, placebo-controlled trials CNS Spectrums  2000 5:58-69  PMID:18296999
• Mason, B. J., Salvato, F. R., Williams, L. D., Ritvo, E. C., Cutler, R. B. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence Archives of General Psychiatry  1999 56:719-724  DOI:10.1001/archpsyc.56.8.719  PMID:10435606
• Mason, B. J., Kocsis, J. H., Melia, D., Khuri, E. T., Sweeney, J., Wells, A., Borg, L., Millman, R. B., Kreek, M. J. Psychiatric comorbidity in methadone maintained patients Journal of Addictive Diseases  1998 17:75-89  DOI:10.1300/J069v17n03_07  PMID:9789161
• Johnson, B. A., Jasinski, D. R., Galloway, G. P., Kranzler, H., Weinreib, R., Anton, R. F., Mason, B. J., Bohn, M. J., Pettinati, H. M., Rawson, R., Clyde, C. Ritanserin in the treatment of alcohol dependence: a multi-center clinical trial Psychopharmacology  1996 128:206-215  DOI:10.1007/s002130050126  PMID:8956382
• Mason, B. J. Dosing issues in the pharmacotherapy of alcoholism Alcoholism-Clinical and Experimental Research  1996 20:A10-A16  DOI:10.1111/j.1530-0277.1996.tb01184.x  PMID:8904989
• Mason, B. J., Kocsis, J. H., Ritvo, E. C., Cutler, R. B. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression JAMA-Journal of the American Medical Association  1996 275:761-767  DOI:10.1001/jama.275.10.761  PMID:8598592
• Ownby, R. L., Mason, B. J., Eisdorfer, C. Alcohol abuse among older adults and the elderly Journal of Practical Psychiatry & Behavioral Health  1996 2:216-222
• Williams, L. D., Mason, B. J., Goldberg, G., Cutler, R. B. Women and minorities representation in alcoholism treatment research Psychopharmacology Bulletin  1996 32:201-204  PMID:8783889
• Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F. R., Goldberg, G., Welch, B., Manteroatienza, E. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence Alcoholism-Clinical and Experimental Research  1994 18:1162-1167  DOI:10.1111/j.1530-0277.1994.tb00098.x  PMID:7847600
• Salvato, F. R., Mason, B. J. Changes in transaminases over the course of a 12-week, double-blind nalmefene trial in a 38-year-old female subject Alcoholism-Clinical and Experimental Research  1994 18:1187-1189  DOI:10.1111/j.1530-0277.1994.tb00102.x  PMID:7847604
• Mason, B. J., Kocsis, J. H., Leon, A. C., Thompson, S., Frances, A. J., Morgan, R. O., Parides, M. K. Measurement of severity and treatment response in dysthymia Psychiatric Annals  1993 23:625-631
• Mason, B. J. Depression in alcoholism: diagnosis and treatment Science Matters  1992 2:33-36
• Mason, B. J., Kocsis, J. H. Desipramine treatment of alcoholism Psychopharmacology Bulletin  1991 27:155-161  PMID:1924663
• Mason, B. J., Kocsis, J. H., Frances, A. J., Mann, J. J. Amoxapine versus amitriptyline for continuation therapy of depression Journal of Clinical Psychopharmacology  1990 10:338-343  PMID:2258450
• Kocsis, J. H., Mason, B. J., Frances, A. J., Sweeney, J., Mann, J. J., Marin, D. Prediction of response of chronic depression to imipramine Journal of Affective Disorders  1989 17:255-260  DOI:10.1016/0165-0327(89)90008-6  PMID:2529294
• Frances, A., Kocsis, J., Marin, D., Manning, D., Markowitz, J., Mason, B., Widiger, T. Diagnostic criteria for dysthymic disorder Psychopharmacology Bulletin  1989 25:325-329  PMID:2697006
• Kocsis, J. H., Frances, A. J., Voss, C., Mason, B. J., Mann, J. J., Sweeney, J. Imipramine and social-vocational adjustment in chronic depression American Journal of Psychiatry  1988 145:997-999  PMID:3394886
• Kocsis, J. H., Frances, A. J., Voss, C., Mann, J. J., Mason, B. J., Sweeney, J. Imipramine treatment for chronic depression Archives of General Psychiatry  1988 45:253-257  DOI:10.1001/archpsyc.1988.01800270071008  PMID:3277579
• Mason, B. J., Kocsis, J. H. Methods and issues in psychopharmacological studies Drugs & Society  1988 2:83-91  DOI:10.1300/J023v02n02_06
• Brown, R. P., Mason, B., Stoll, P., Brizer, D., Kocsis, J., Stokes, P. E., Mann, J. J. Adrenocortical function and suicidal behavior in depressive disorders Psychiatry Research  1986 17:317-323  DOI:10.1016/0165-1781(86)90079-x  PMID:3714913
• Kocsis, J. H., Kennedy, S., Brown, R. P., Mann, J. J., Mason, B. Suicide and adrenocortical function Psychopharmacology Bulletin  1986 22:650-655  PMID:3797571
• Exner Jr., J. E., Thomas, E. A., Mason, B. Children's Rorschachs: description and prediction Journal of Personality Assessment  1985 49:13-20  DOI:10.1207/s15327752jpa4901_3  PMID:3989648
• Escobar, J. I., Mann, J. J., Keller, J., Wilkins, J., Mason, B., Mills, M. J. Comparison of injectable molindone and haloperidol followed by oral dosage forms in acutely ill schizophrenics Journal of Clinical Psychiatry  1985 46:15-19  PMID:3894337
• Kocsis, J. H., Frances, A., Mann, J. J., Sweeney, J., Voss, C., Mason, B., Brown, R. P. Imipramine for treatment of chronic depression Psychopharmacology Bulletin  1985 21:698-700  PMID:3898184
• Mason, B. J., Cohen, J. B., Exner, J. E., Jr. Schizophrenic, depressive, and nonpatient personality organizations described by Rorschach factor structures Journal of Personality Assessment  1985 49:295-305  DOI:10.1207/s15327752jpa4903_16  PMID:4032208